NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
8.96
-0.86 (-8.76%)
At close: Nov 7, 2025, 4:00 PM EST
9.00
+0.04 (0.45%)
After-hours: Nov 7, 2025, 6:30 PM EST
NextCure Market Cap
NextCure has a market cap or net worth of $23.98 million as of November 7, 2025. Its market cap has decreased by -37.44% in one year.
Market Cap
23.98M
Enterprise Value
-721.05K
1-Year Change
-37.44%
Ranking
Category
Stock Price
$8.96
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $23.98M, a decrease of -94.51%. That is a compound annual growth rate of -35.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 23.98M | 11.04% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |